Aspira Women's Health issues Series A common stock purchase warrants
Aspira Women's Health Inc. filed a warrant agreement allowing holders to purchase common stock between June 5, 2026 and June 5, 2029. The warrant issuance is a financing mechanism that provides the company with capital flexibility while offering investors equity upside potential.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day